For: | Stella L, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World J Gastroenterol 2022; 28(21): 2251-2281 [PMID: 35800182 DOI: 10.3748/wjg.v28.i21.2251] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v28/i21/2251.htm |
Number | Citing Articles |
1 |
Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea, Marco Lioce, Palma Fedele. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma. Cancers 2023; 15(3): 654 doi: 10.3390/cancers15030654
|
2 |
You-Wen Tan. Risk stratification of primary liver cancer. World Journal of Clinical Cases 2022; 10(26): 9545-9549 doi: 10.12998/wjcc.v10.i26.9545
|
3 |
Dan Nicolae Florescu, Mihail-Virgil Boldeanu, Robert-Emmanuel Șerban, Lucian Mihai Florescu, Mircea-Sebastian Serbanescu, Mihaela Ionescu, Liliana Streba, Cristian Constantin, Cristin Constantin Vere. Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer. Life 2023; 13(12): 2261 doi: 10.3390/life13122261
|
4 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7): 1632 doi: 10.3390/microorganisms11071632
|
5 |
Ling Yu, Shengmao Liu, Shengnan Jia, Feng Xu. Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies. Biomedicine & Pharmacotherapy 2023; 165: 115049 doi: 10.1016/j.biopha.2023.115049
|
6 |
Jing Wu, Fang Zhang, Hongji Tao, Waqas Nawaz, Deyan Chen, Zhiwei Wu. The potential roles of interleukin-25 in infectious diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.986118
|
7 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
|
8 |
Jiarui Zheng, Xiaoxiao Wang, Zilong Wang, Linxiang Huang, Yandi Xie, Suzhen Jiang, Bo Feng. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population — China, 2010–2023. China CDC Weekly 2023; 5(49): 1107 doi: 10.46234/ccdcw2023.207
|
9 |
Marina Manea, Dimitri Apostol, Ileana Constantinescu. A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus. Diagnostics 2023; 13(22): 3425 doi: 10.3390/diagnostics13223425
|
10 |
Jiezuan Yang, Shaoyan Xu, Jinlin Cheng, Xuying Yin, Dong Yan, Xuefen Li. CXCL10 and its receptor in patients with chronic hepatitis B and their ability to predict HBeAg seroconversion during antiviral treatment with TDF. Journal of Medical Virology 2024; 96(3) doi: 10.1002/jmv.29516
|
11 |
Francesca Parisi, Niccolò Fonti, Francesca Millanta, Giulia Freer, Mauro Pistello, Alessandro Poli. Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis. Infectious Agents and Cancer 2023; 18(1) doi: 10.1186/s13027-023-00518-7
|
12 |
Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia. Hepatitis B Virus and microRNAs: A Bioinformatics Approach. International Journal of Molecular Sciences 2023; 24(24): 17224 doi: 10.3390/ijms242417224
|
13 |
Giulia Collatuzzo, Carlo La Vecchia, Fabio Parazzini, Gianfranco Alicandro, Federica Turati, Matteo Di Maso, Matteo Malvezzi, Claudio Pelucchi, Eva Negri, Paolo Boffetta. Cancers attributable to infectious agents in Italy. European Journal of Cancer 2023; 183: 69 doi: 10.1016/j.ejca.2023.01.010
|
14 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Dimitris Matthaios, Michalis V. Karamouzis. An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 2023; 24(8): 7168 doi: 10.3390/ijms24087168
|
15 |
Fizzah Abid, Khushbukhat Khan, Yasmin Badshah, Naeem Mahmood Ashraf, Maria Shabbir, Arslan Hamid, Tayyaba Afsar, Ali Almajwal, Suhail Razak. Non-synonymous SNPs variants of PRKCG and its association with oncogenes predispose to hepatocellular carcinoma. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02965-z
|
16 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
17 |
Dallyla Jennifer Morais de Sousa, Kynnara Gabriella Feitosa de Oliveira, Irislene Costa Pereira, Glauto Tuquarre Melo do Nascimento, Clenio Oliveira Barrense, Jorddam Almondes Martins, Beatriz de Mello Pereira Rêgo, Tiago Eugênio Oliveira da Silva, Felipe Cavalcanti Carneiro da Silva, Francisco Leonardo Torres-Leal. Dietary restriction and hepatic cancer: Systematic review and meta-analysis of animal studies. Critical Reviews in Oncology/Hematology 2024; 196: 104264 doi: 10.1016/j.critrevonc.2024.104264
|
18 |
Iman H. Ibrahim, Ola Sayed M. Ali, Adel A. El-Sahar, Mohamed Elrefaei, Nabila El-Sheikh. Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients’ PBMCs. Journal of Clinical and Experimental Hepatology 2023; 13(6): 1008 doi: 10.1016/j.jceh.2023.06.004
|
19 |
Yongchao Zhang, Hualei Chen, Shanshan Chen, Youjia Duan, Long Cheng, Jie Gao, Wei Li. Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Journal of Hepatocellular Carcinoma 2022; : 1309 doi: 10.2147/JHC.S386264
|
20 |
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma 2023; : 713 doi: 10.2147/JHC.S384751
|
21 |
Chi Ma, Ling Tang, Jiaqi Yao, Guang Tan. Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis. Journal of Personalized Medicine 2024; 14(3): 262 doi: 10.3390/jpm14030262
|
22 |
Niloufar Sadat Kalaki, Mozhgan Ahmadzadeh, Atena Mansouri, Mohammadreza Saberiyan, Mohammad Hadi Karbalaie Niya. Identification of hub genes and pathways in hepatitis B virus‐associated hepatocellular carcinoma: A comprehensive in silico study. Health Science Reports 2024; 7(6) doi: 10.1002/hsr2.2185
|
23 |
Marina Manea, Ion Mărunțelu, Ileana Constantinescu. Extended analysis on peripheral blood cytokines correlated with hepatitis B virus viral load in chronically infected patients – a systematic review and meta-analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429926
|
24 |
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article. International Journal of Molecular Sciences 2023; 24(22): 16048 doi: 10.3390/ijms242216048
|